Cite
Alternating chemotherapy with amrubicin plus cisplatin and weekly administration of irinotecan plus cisplatin for extensive-stage small cell lung cancer.
MLA
Noro, Rintaro, et al. “Alternating Chemotherapy with Amrubicin plus Cisplatin and Weekly Administration of Irinotecan plus Cisplatin for Extensive-Stage Small Cell Lung Cancer.” Anticancer Research, vol. 33, no. 3, Mar. 2013, pp. 1117–23. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=23482789&authtype=sso&custid=ns315887.
APA
Noro, R., Yoshimura, A., Yamamoto, K., Miyanaga, A., Mizutani, H., Minegishi, Y., Seike, M., Kubota, K., Kosaihira, S., Hino, M., Ando, M., Nomura, K., Okano, T., Kobayashi, K., Uematsu, K., & Gemma, A. (2013). Alternating chemotherapy with amrubicin plus cisplatin and weekly administration of irinotecan plus cisplatin for extensive-stage small cell lung cancer. Anticancer Research, 33(3), 1117–1123.
Chicago
Noro, Rintaro, Akinobu Yoshimura, Kazuo Yamamoto, Akihiko Miyanaga, Hideaki Mizutani, Yuji Minegishi, Masahiro Seike, et al. 2013. “Alternating Chemotherapy with Amrubicin plus Cisplatin and Weekly Administration of Irinotecan plus Cisplatin for Extensive-Stage Small Cell Lung Cancer.” Anticancer Research 33 (3): 1117–23. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=23482789&authtype=sso&custid=ns315887.